Staphylococcal presence alters thrombus formation under physiological shear conditions in whole blood studies

Annals of Biomedical Engineering
Michael A Johnson, Julia M Ross

Abstract

The ability of platelets to aggregate at a site of injury and form a thrombus is central to normal hemostasis and host survival. Staphylococcus aureus is a major pathogenic organism that has been described as interacting with platelets and promoting platelet aggregation. However, the fundamental effects of bacterial presence on thrombus formation are poorly understood. In this study, we quantify thrombus formation in whole blood in the presence and absence of S. aureus under physiological shear conditions. Using confocal microscopy we observed that S. aureus causes a reduction in thrombus volumes and alters the morphological structure of the growing thrombi.

References

Aug 1, 1988·The Journal of Experimental Medicine·S BhakdiL Roka
Mar 8, 1996·The Journal of Biological Chemistry·B Felding-HabermannZ M Ruggeri
Feb 7, 1998·The Journal of Clinical Investigation·S GotoZ M Ruggeri
Jan 23, 1999·Infection and Immunity·N MohamedJ M Ross
Nov 27, 1999·Journal of Microbiological Methods·X YangZ Lewandowski
Mar 23, 2000·The Journal of Clinical Investigation·S KulkarniS P Jackson
Mar 28, 2001·Water Research·X YangZ Lewandowski
Apr 9, 2001·Infection and Immunity·I R SibooP M Sullam
Apr 11, 2001·Emerging Infectious Diseases·H F Chambers
Oct 24, 2002·Journal of Theoretical Biology·Robert D Guy, Aaron L Fogelson
Oct 24, 2002·Blood·Ulf SjöbringZaverio M Ruggeri
Apr 2, 2003·The Journal of Cell Biology·Warwick S NesbittShaun P Jackson
Apr 15, 2004·Biofouling·Haluk BeyenalGary Harkin
Apr 23, 2004·Journal of Thrombosis and Haemostasis : JTH·R W FarndaleP G de Groot
Jul 3, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Christelle LecutJohan W M Heemskerk
Jul 9, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Parag PawarKonstantinos Konstantopoulos
Sep 4, 2004·The Journal of Biological Chemistry·Pia R-M SiljanderRichard W Farndale
Sep 9, 2004·Seminars in Thrombosis and Hemostasis·Mark L Kahn
Oct 19, 2004·Journal of Microbiological Methods·Haluk BeyenalGary Harkin
May 12, 2005·Thrombosis and Haemostasis·Oonagh ShannonJan-Ingmar Flock
Feb 16, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Larry J StrausbaughRobert A Weinstein

❮ Previous
Next ❯

Citations

Mar 17, 2011·Biomedical Microdevices·Cari A LauniereDavid T Eddington

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Blood Coagulation Signaling Pathways

Coagulation is the process by which a blood clot is formed. This process includes both the formation of a platelet plug as well as a cascade of clotting factors resulting in the formation of fibrin strands. Find the latest research on coagulation signaling pathways here.